What the Mount Raymond acquisition means for SLAM Exploration Ltd.’s Goodwin project scale (TSXV: SXL)
Read More 5 minute read Pharma Industry News Precision BioSciences $75m stock and warrant offering sparks debate over biotech funding momentum Precision BioSciences completes a $75 million stock and warrant offering to fund its ARCUS gene-editing pipeline — find out how this move reflects broader biotech funding trends. bySoujanya RaviNovember 11, 2025